↓ Skip to main content

Cochrane Database of Systematic Reviews

Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer

Overview of attention for article published in Cochrane database of systematic reviews, April 2017
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Readers on

mendeley
26 Mendeley
Title
Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer
Published in
Cochrane database of systematic reviews, April 2017
DOI 10.1002/14651858.cd012644
Authors

Fabio Y Moraes, Luke A Perry, Jahan C Penny‐Dimri, Dhruvesh Ramson, Tiago B de Castria, Rayleen V Bowman, Fábio N Santos, Kwun M Fong, Rachel Riera

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 23%
Student > Master 4 15%
Student > Ph. D. Student 4 15%
Student > Postgraduate 3 12%
Researcher 2 8%
Other 2 8%
Unknown 5 19%
Readers by discipline Count As %
Medicine and Dentistry 13 50%
Nursing and Health Professions 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Arts and Humanities 1 4%
Other 3 12%
Unknown 5 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2017.
All research outputs
#20,233,045
of 25,728,855 outputs
Outputs from Cochrane database of systematic reviews
#12,094
of 13,136 outputs
Outputs of similar age
#234,884
of 324,494 outputs
Outputs of similar age from Cochrane database of systematic reviews
#219
of 238 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,136 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,494 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 238 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.